A tale of two drug trials
Two companies have announced the results of clinical trials of drugs for pulmonary arterial hypertension recently, neatly illustrating successful and unsuccessful results.
Last week, Gossamer Bio announced that their drug, seralutinib, failed to meet the primary endpoint of its phase 3 PROSERA clinical trial. Gossamer’s stock price dropped precipitously. Interestingly, one of the reasons the study failed may have been an unusually good response to the placebo in some locations, and not a poor response to seralutinib at all! The study did have some promising results, so Gossamer is still looking for a path forward for seralutinib, particularly in the United States.
This week, United Therapeutics announced that its phase 3 ADVANCE OUTCOMES study of the drug ralinepag did meet its primary endpoint, with results indicating it reduced the risk of clinical worsening by 55% compared to placebo. The company’s stock is trading near its 52-week high price, and they will seek approval for ralinepag in the US later in 2026.
Together, these contrasting outcomes are a reminder that while the path to new pulmonary arterial hypertension treatments is rarely straightforward, each trial—whether it meets its endpoint or not—moves the field a step closer to better options for patients.
mình có lần lướt đọc mấy trao đổi trên mạng شيخ روحاني thì thấy nhắc nên cũng tò mò mở ra xem thử cho biết. mình không tìm hiểu sâu chỉ xem qua trong thời gian ngắn để quan sát bố cục cách sắp xếp جلب الحبيب các mục và trình bày nội جلب الحبيب dung tổng thể. cảm giác là các phần được trình bày khá gọn, các hurentest berlin mục rõ ràng Huren Berlin nên đọc lướt cũng không bị rối với mình như vậy là đủ để nắm tin cơ bản rồi. جلب الحبيب
👍
Thank you for creating this informative resource. The article explains the subject in a way that is suitable for people with different levels of knowledge. I hope the website continues publishing practical guides that answer common questions in simple language.
Raxi Win Register
I enjoyed the clear explanations and the overall organization of this post. Each section contributes to understanding the topic, and the language remains straightforward. Content like this encourages readers to keep learning and explore additional resources for more detailed information.
Bharat Club Login
I appreciate the clear presentation of the information in this post. The topic is explained in simple language, making it accessible to many readers. Thanks for sharing practical knowledge and creating a comfortable reading experience for your audience.
jalwagame
This article offers a helpful explanation for readers who want to learn about the subject. The information is presented logically, and the writing feels natural. Keep publishing useful content that supports learning and provides readers with relevant information.
jalwa